AP
INSP icon

AtonRa Partners’s Inspire Medical Systems INSP Stock Holding History

AtonRa Partners’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$643K Sell
3,163
-260
-8% -$42.1K 1.28% 18
2023
Q3 		$679K Sell
3,423
-130
-4% -$32.8K 1.42% 9
2023
Q2 		$1.15M Sell
3,553
-605
-15% -$173K 1.79% 7
2023
Q1 		$973K Sell
4,158
-585
-12% -$148K 1.42% 10
2022
Q4 		$1.19M Sell
4,743
-1,470
-24% -$313K 1.52% 11
2022
Q3 		$1.1M Sell
6,213
-1,727
-22% -$347K 1.08% 35
2022
Q2 		$1.45M Sell
7,940
-761
-9% -$152K 1.33% 14
2022
Q1 		$2.23M Sell
8,701
-4,311
-33% -$985K 1.21% 27
2021
Q4 		$2.99M Buy
13,012
+4,457
+52% +$1.09M 1.04% 41
2021
Q3 		$1.99M Buy
8,555
+1,229
+17% +$256K 0.67% 64
2021
Q2 		$1.42M Buy
7,326
+120
+2% +$23.8K 0.52% 70
2021
Q1 		$1.49M Buy
7,206
+914
+15% +$194K 0.67% 61
2020
Q4 		$1.18M Buy
+6,292
New +$1.03M 0.58% 59

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

AtonRa Partners's INSP Position: Q4 2023 in Review

AtonRa Partners reduced its Inspire Medical Systems (INSP) stake by 7.6% in Q4 2023, selling an estimated $42.1K and leaving 3,163 shares worth $643K. The position accounts for 1.28% of the portfolio, ranked #18.

AtonRa Partners first reported a position in INSP in Q4 2020 and has held it in 13 quarters since. The position peaked at $2.99M in Q4 2021. 343 funds tracked by Wall St. Rank hold INSP as of Q4 2023.

  • AtonRa Partners held 3,163 shares of Inspire Medical Systems worth $643K as of Q4 2023.
  • AtonRa Partners sold 260 Inspire Medical Systems shares in Q4 2023, an estimated $42.1K.
  • Inspire Medical Systems made up 1.28% of AtonRa Partners's portfolio in Q4 2023, its #18 holding.
  • AtonRa Partners first reported a position in Inspire Medical Systems in Q4 2020 and has held it in 13 quarters since.
  • AtonRa Partners's Inspire Medical Systems position peaked at $2.99M in Q4 2021.
  • 343 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q4 2023.

Based on AtonRa Partners's 13F filing for Q4 2023, filed 5 Feb 2024.